Copyright Reports & Markets. All rights reserved.

China Biotherapeutics Market Report 2018

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Definition and Specification
    • 1.2 Report Overview
      • 1.2.1 Manufacturers Overview
      • 1.2.2 Regions Overview
      • 1.2.3 Type Overview
      • 1.2.4 Application Overview
    • 1.3 Industrial Chain
      • 1.3.1 Biotherapeutics Overall Industrial Chain
      • 1.3.2 Upstream
      • 1.3.3 Downstream
    • 1.4 Industry Situation
      • 1.4.1 Industrial Policy
      • 1.4.2 Product Preference
      • 1.4.3 Economic/Political Environment
    • 1.5 SWOT Analysis

    2 Market Analysis by Types

    • 2.1 Overall Market Performance(Volume)
      • 2.1.1 Transfection Market Performance (Volume)
      • 2.1.2 Single Cell Cloning: Manual Limited Dilution Cloning, FACS, ClonePix and Others Market Performance (Volume)
    • 2.2 Overall Market Performance(Value)
      • 2.1.1 Transfection Market Performance (Value)
      • 2.1.2 Single Cell Cloning: Manual Limited Dilution Cloning, FACS, ClonePix and Others Market Performance (Value)

    3 Product Application Market

    • 3.1 Overall Market Performance (Volume)
      • 3.1.1 Clinical Treatment Market Performance (Volume)
      • 3.1.2 Scientific Research Market Performance (Volume)
      • 3.1.3 Other Market Performance (Volume)

    4 Manufacturers Profiles/Analysis

    • 4.1 Beckman Coulter
      • 4.1.1 Beckman Coulter Profiles
      • 4.1.2 Beckman Coulter Product Information
      • 4.1.3 Beckman Coulter Biotherapeutics Business Performance
      • 4.1.4 Beckman Coulter Biotherapeutics Business Development and Market Status
    • 4.2 Boehringer Ingelheim Pharma
      • 4.2.1 Boehringer Ingelheim Pharma Profiles
      • 4.2.2 Boehringer Ingelheim Pharma Product Information
      • 4.2.3 Boehringer Ingelheim Pharma Biotherapeutics Business Performance
      • 4.2.4 Boehringer Ingelheim Pharma Biotherapeutics Business Development and Market Status
    • 4.3 CMC Biologics
      • 4.3.1 CMC Biologics Profiles
      • 4.3.2 CMC Biologics Product Information
      • 4.3.3 CMC Biologics Biotherapeutics Business Performance
      • 4.3.4 CMC Biologics Biotherapeutics Business Development and Market Status
    • 4.4 Lonza Group
      • 4.4.1 Lonza Group Profiles
      • 4.4.2 Lonza Group Product Information
      • 4.4.3 Lonza Group Biotherapeutics Business Performance
      • 4.4.4 Lonza Group Biotherapeutics Business Development and Market Status
    • 4.5 Partec
      • 4.5.1 Partec Profiles
      • 4.5.2 Partec Product Information
      • 4.5.3 Partec Biotherapeutics Business Performance
      • 4.5.4 Partec Biotherapeutics Business Development and Market Status
    • 4.6 ProBioGen
      • 4.6.1 ProBioGen Profiles
      • 4.6.2 ProBioGen Product Information
      • 4.6.3 ProBioGen Biotherapeutics Business Performance
      • 4.6.4 ProBioGen Biotherapeutics Business Development and Market Status
    • 4.7 SAFC
      • 4.7.1 SAFC Profiles
      • 4.7.2 SAFC Product Information
      • 4.7.3 SAFC Biotherapeutics Business Performance
      • 4.7.4 SAFC Biotherapeutics Business Development and Market Status
    • 4.8 Selexis
      • 4.8.1 Selexis Profiles
      • 4.8.2 Selexis Product Information
      • 4.8.3 Selexis Biotherapeutics Business Performance
      • 4.8.4 Selexis Biotherapeutics Business Development and Market Status
    • 4.9 Thermo Fisher Scientific
      • 4.9.1 Thermo Fisher Scientific Profiles
      • 4.9.2 Thermo Fisher Scientific Product Information
      • 4.9.3 Thermo Fisher Scientific Biotherapeutics Business Performance
      • 4.9.4 Thermo Fisher Scientific Biotherapeutics Business Development and Market Status

    5 Market Performance for Manufacturers

    • 5.1 China Biotherapeutics Sales (K Units) and Market Share by Manufacturers 2013-2018
    • 5.2 China Biotherapeutics Revenue (M USD) and Market Share by Manufacturers 2013-2018
    • 5.3 China Biotherapeutics Price (USD/Unit) of Manufacturers 2013-2018
    • 5.4 China Biotherapeutics Gross Margin of Manufacturers 2013-2018
    • 5.5 Market Concentration

    6 Regions Market Performance for Manufacturers

    • 6.1 South China Market Performance for Manufacturers
      • 6.1.1 South China Biotherapeutics Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.1.2 South China Biotherapeutics Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.1.3 South China Biotherapeutics Price (USD/Unit) of Manufacturers 2013-2018
      • 6.1.4 South China Biotherapeutics Gross Margin of Manufacturers 2013-2018
      • 6.1.5 Market Concentration
    • 6.2 East China Market Performance for Manufacturers
      • 6.2.1 East China Biotherapeutics Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.2.2 East China Biotherapeutics Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.2.3 East China Biotherapeutics Price (USD/Unit) of Manufacturers 2013-2018
      • 6.2.4 East China Biotherapeutics Gross Margin of Manufacturers 2013-2018
      • 6.2.5 Market Concentration
    • 6.3 Southwest China Market Performance for Manufacturers
      • 6.3.1 Southwest China Biotherapeutics Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.3.2 Southwest China Biotherapeutics Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.3.3 Southwest China Biotherapeutics Price (USD/Unit) of Manufacturers 2013-2018
      • 6.3.4 Southwest China Biotherapeutics Gross Margin of Manufacturers 2013-2018
      • 6.3.5 Market Concentration
    • 6.4 Northeast China Market Performance for Manufacturers
      • 6.4.1 Northeast China Biotherapeutics Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.4.2 Northeast China Biotherapeutics Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.4.3 Northeast China Biotherapeutics Price (USD/Unit) of Manufacturers 2013-2018
      • 6.4.4 Northeast China Biotherapeutics Gross Margin of Manufacturers 2013-2018
      • 6.4.5 Market Concentration
    • 6.5 North China Market Performance for Manufacturers
      • 6.5.1 North China Biotherapeutics Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.5.2 North China Biotherapeutics Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.5.3 North China Biotherapeutics Price (USD/Unit) of Manufacturers 2013-2018
      • 6.5.4 North China Biotherapeutics Gross Margin of Manufacturers 2013-2018
      • 6.5.5 Market Concentration
    • 6.6 Central China Market Performance for Manufacturers
      • 6.6.1 Central China Biotherapeutics Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.6.2 Central China Biotherapeutics Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.6.3 Central China Biotherapeutics Price (USD/Unit) of Manufacturers 2013-2018
      • 6.6.4 Central China Biotherapeutics Gross Margin of Manufacturers 2013-2018
      • 6.6.5 Market Concentration
    • 6.7 Northwest China Market Performance for Manufacturers
      • 6.7.1 Northwest China Biotherapeutics Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.7.2 Northwest China Biotherapeutics Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.7.3 Northwest China Biotherapeutics Price (USD/Unit) of Manufacturers 2013-2018
      • 6.7.4 Northwest China Biotherapeutics Gross Margin of Manufacturers 2013-2018
      • 6.7.5 Market Concentration

    7 China Biotherapeutics Market Performance (Sales Point)

    • 7.1 China Biotherapeutics Sales (K Units) and Market Share by Regions 2013-2018
    • 7.2 China Biotherapeutics Revenue (M USD) and Market Share by Regions 2013-2018
    • 7.3 China Biotherapeutics Price (USD/Unit) by Regions 2013-2018
    • 7.4 China Biotherapeutics Gross Margin by Regions 2013-2018

    8 Development Trend for Regions (Sales Point)

    • 8.1 China Biotherapeutics Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.2 South China Biotherapeutics Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.3 East China Biotherapeutics Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.4 Southwest China Biotherapeutics Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.5 Northeast China Biotherapeutics Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.6 North China Biotherapeutics Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.7 Central China Biotherapeutics Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.8 Northwest China Biotherapeutics Sales and Growth, Sales Value and Growth Rate2013-2018

    9 Upstream Source, Technology and Cost

    • 9.1 Upstream Source
    • 9.2 Technology
    • 9.3 Cost

    10 Channel Analysis

    • 10.1 Market Channel
    • 10.2 Distributors

    11 Consumer Analysis

    • 11.1 Clinical Treatment Industry
    • 11.2 Scientific Research Industry
    • 11.3 Other Industry

    12 Market Forecast 2019-2024

    • 12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2019-2024
      • 12.1.1 China Biotherapeutics Sales (K Units), Revenue (M USD) and Market Share by Regions 2019-2024
      • 12.1.2 China Biotherapeutics Sales (K Units) and Growth Rate 2019-2024
      • 12.1.3 South China Biotherapeutics Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.4 East China Biotherapeutics Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.5 Southwest China Biotherapeutics Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.6 Northeast China Biotherapeutics Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.7 North China Biotherapeutics Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.8 Central China Biotherapeutics Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.9 Northwest China Biotherapeutics Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
    • 12.3 Sales (K Units), Revenue (M USD) by Types 2019-2024
      • 12.3.1 Overall Market Performance
      • 12.3.2 Transfection Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.3.3 Single Cell Cloning: Manual Limited Dilution Cloning, FACS, ClonePix and Others Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
    • 12.4 Sales by Application 2019-2024
      • 12.4.1 Overall Market Performance
      • 12.4.2 Clinical Treatment Sales and and Growth Rate 2019-2024
      • 12.4.3 Scientific Research Sales and and Growth Rate 2019-2024
      • 12.4.4 Other Sales and and Growth Rate 2019-2024
    • 12.5 Price (USD/Unit) and Gross Profit
      • 12.5.1 China Biotherapeutics Price (USD/Unit) Trend 2019-2024
      • 12.5.2 China Biotherapeutics Gross Profit Trend 2019-2024

    13 Conclusion

    Geographically, this report split China into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Biotherapeutics for these regions, from 2012 to 2023 (forecast), including
    South China
    East China
    Southwest China
    Northeast China
    North China
    Central China
    Northwest China

    China Biotherapeutics market competition by top manufacturers/players, with Biotherapeutics sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Beckman Coulter
    Boehringer Ingelheim Pharma
    CMC Biologics
    Lonza Group
    Partec
    ProBioGen
    SAFC
    Selexis
    Thermo Fisher Scientific

    On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
    Transfection
    Single Cell Cloning: Manual Limited Dilution Cloning, FACS, ClonePix and Others

    On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Biotherapeutics for each application, including
    Clinical Treatment
    Scientific Research
    Other

    If you have any special requirements, please let us know and we will offer you the report as you want.

    Buy now